Actinium and Memorial Sloan Kettering Cancer Center Sign Agreement in Respect of Certain Liquidity Matters Dec 24, 2015
Actinium Announces Iomab-B IND Has Been Cleared By FDA; Pivotal, Phase 3 Trial to Proceed Dec 17, 2015
Clinical Trial Results for Actimab-A Presented at the 57th American Society of Hematology Annual Meeting Dec 8, 2015
Actinium Announces Strong Presence at 57th American Society of Hematology Annual Meeting December 4-8, 2015 Dec 1, 2015
Actinium Files Orphan Drug Application for Use of Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients Nov 23, 2015
Actinium Pharmaceuticals Further Strengthens Product Development Efforts With Senior Level Hires Nov 4, 2015
